With this, for all our USFDA facilities, EIRs are in place
Alembic Pharmaceuticals Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the inspection carried out by them at our Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav from 28th February, 2024 to 8th March, 2024.
With this, for all our USFDA facilities, EIRs are in place.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)
.jpg)
